Literature DB >> 9647550

Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.

H O Critchley1, H Wang, R L Jones, R W Kelly, T A Drudy, A E Gebbie, C H Buckley, A S McNeilly, A F Glasier.   

Abstract

Irregular bleeding remains a common reason for the discontinuation of progestin-only contraception. The levonorgestrel releasing intrauterine system (LNG-IUS) has profound morphological effects upon the endometrium. Specific features are gland atrophy and extensive decidual transformation of the stroma. Morphological changes in the endometrium may be associated with perturbation of mechanisms regulating normal endometrial function. This study describes endometrial stromal and glandular features prior to and up to 12 months following insertion of the LNG-IUS. Comparison is made with first trimester decidua. In order to elucidate further mechanisms governing endometrial function with local intrauterine delivery of LNG, we here report histological features consistent with decidualization; a significant increase in granulocyte-macrophage colony stimulating factor (GM-CSF) immunoreactivity in decidualized stromal cells; glandular and stromal prolactin receptor expression and an infiltrate of CD56 + large granular lymphocytes and CD68 + macrophages. We are unaware of previous reports which have documented longitudinally both morphological and functional observations in endometrium exposed to local intrauterine levonorgestrel delivery. These studies demonstrate that long-term administration of intrauterine levonorgestrel results in features of altered morphology and function. No correlation was apparent between the end points in the study and the bleeding patterns described by the subjects. Further evaluation of these features in the context of menstrual bleeding experience may contribute to a better understanding of this troublesome side-effect which often leads to dissatisfaction and discontinuation of the intrauterine system.

Entities:  

Keywords:  Biology; Clinical Research; Contraception; Contraceptive Agents, Female--pharmacodynamics; Contraceptive Agents, Progestin--pharmacodynamics; Contraceptive Agents--pharmacodynamics; Contraceptive Methods; Cytochemical Effects; Cytologic Effects; Decidual Cell Reaction; Developed Countries; Diseases; Endometrial Effects; Endometrium; Europe; Family Planning; Genitalia; Genitalia, Female; Histochemical Effects; Iud; Iud, Hormone Releasing; Levonorgestrel--pharmacodynamics; Menstruation Disorders--etiology; Northern Europe; Physiology; Research Methodology; Research Report; United Kingdom; Urogenital System; Uterus

Mesh:

Substances:

Year:  1998        PMID: 9647550     DOI: 10.1093/humrep/13.5.1218

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  11 in total

1.  The effects of the levonorgestrel intrauterine system (Mirena coil) on endometrial morphology.

Authors:  V Phillips; C T Graham; S Manek; W G McCluggage
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

2.  Morphological and Ultrastructural Changes in Human Endometrium Following Low-Dose Levonorgestrel Contraceptive Intrauterine Systems (LNG-IUS-12) 13.5 mg.

Authors:  Minghan Chai; Shili Su; Baihua Dong
Journal:  J Obstet Gynaecol India       Date:  2014-10-29

3.  Tamoxifen for the prevention of unscheduled bleeding in new users of the levonorgestrel 52-mg intrauterine system: a randomized controlled trial.

Authors:  Megan A Cohen; Katharine B Simmons; Alison B Edelman; Jeffrey T Jensen
Journal:  Contraception       Date:  2019-06-18       Impact factor: 3.375

Review 4.  Levonorgestrel IUD: is there a long-lasting effect on return to fertility?

Authors:  Erin Dinehart; Ruth B Lathi; Lusine Aghajanova
Journal:  J Assist Reprod Genet       Date:  2019-11-11       Impact factor: 3.412

5.  Progesterone-based intrauterine device use is associated with a thinner apical layer of the human ectocervical epithelium and a lower ZO-1 mRNA expression.

Authors:  Annelie Tjernlund; Ann M Carias; Sonia Andersson; Susanna Gustafsson-Sanchez; Maria Röhl; Pernilla Petersson; Andrea Introini; Thomas J Hope; Kristina Broliden
Journal:  Biol Reprod       Date:  2015-01-14       Impact factor: 4.285

6.  Benefit-risk assessment of the levonorgestrel intrauterine system in contraception.

Authors:  Tiina Backman
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

7.  Abnormal uterine bleeding during progestin-only contraception may result from free radical-induced alterations in angiopoietin expression.

Authors:  Graciela Krikun; Hilary Critchley; Frederick Schatz; Livia Wan; Rebeca Caze; Rebecca N Baergen; Charles J Lockwood
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

8.  Uterine synechiae after intrauterine device use: a case series.

Authors:  Mary Kathryn Abel; Kaitlyn Wald; Marcelle I Cedars; Martha Noel
Journal:  J Assist Reprod Genet       Date:  2021-04-08       Impact factor: 3.357

9.  Intercellular adhesion molecule-1 expression in human endometrium: implications for long term progestin only contraception.

Authors:  Frederick Schatz; Graciela Krikun; Rebecca N Baergen; Hilary O D Critchley; Edward Kuczynski; Charles J Lockwood
Journal:  Reprod Biol Endocrinol       Date:  2006-01-30       Impact factor: 5.211

10.  Development of an animal experimental model to study the effects of levonorgestrel on the human endometrium.

Authors:  M-L Alvarez Gonzalez; C Galant; F Frankenne; M Nisolle; S Labied; J-M Foidart; E Marbaix; A Béliard
Journal:  Hum Reprod       Date:  2008-12-17       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.